Edwards Lifesciences Japan — Total other segment items decreased by 39.5% to -$6.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.4%, from -$4.60M to -$6.00M. Over 3 years (FY 2022 to FY 2025), Japan — Total other segment items shows an upward trend with a -44.4% CAGR.
High volatility or large negative values may signal non-recurring operational disruptions or restructuring activities that impact regional profitability.
This metric captures miscellaneous income or expense items specifically attributed to the Japanese segment that are not...
Similar to 'other operating income/expense' line items found in segment reporting for large-cap healthcare firms.
ew_segment_japan_total_other_segment_items| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$14.53M | -$14.53M | -$14.53M | -$14.53M | $5.33M | $5.33M | $5.33M | $5.33M | $700.00K | -$3.60M | -$2.40M | -$1.50M | -$4.60M | -$200.00K | -$900.00K | -$4.30M | -$6.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +136.7% | +0.0% | +0.0% | +0.0% | -86.9% | -614.3% | +33.3% | +37.5% | -206.7% | +95.7% | -350.0% | -377.8% | -39.5% |
| YoY Change | — | — | — | — | +136.7% | +136.7% | +136.7% | +136.7% | -86.9% | -167.6% | -145.1% | -128.2% | -757.1% | +94.4% | +62.5% | -186.7% | -30.4% |